Cocaine user experiences reduced withdrawal cravings with GLP-1 therapy, case study reports
A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published in the Journal of Medical Case Reports,
GLP-1 Medications Reduce Alcohol Cravings, Per a New Study
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder. How the meds work in the brain.
GLP-1 Drugs Like Ozempic Reduce Cocaine Cravings, Case Study Finds
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol and cocaine.
Ozempic Reduces Desire to Binge Alcohol, Suggests Amazing New Study
People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new study confirms there's likely something to the anecdotes, with a staggering 30 percent reduction in alcohol consumption per drinking day for those given the medication,
Semaglutide shows promise in reducing alcohol cravings
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
Ozempic may reduce alcohol cravings, new study finds
A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.
New Drug in Development to Offset Bone and Muscle Loss From GLP-1 Drugs, but Does It Underscore a Bigger Problem?
Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...
BioSpace7h
Illegal GLP-1 Ingredients ‘Flooding’ Into US: Report
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizes
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
Medical News Today3d
What's the latest on cholesterol, heart health, GLP-1 drugs, and more?
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Dallas Morning News8d
All-you-can’t-eat: GLP-1 drugs pose new challenges for restaurants, but how do they work?
When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.
Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
Medical News Today3d
Novel antibody could help prevent bone, muscle loss due to GLP-1 drugs
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
News Nation on MSN9d
Study finds rare vision issues in taking GLP-1 weight loss drugs
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...
24/7 Wall St. on MSN3h
Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...